Angiogenic Gene-Modified Fibroblasts for Induction of Localized Angiogenesis

Journal of Surgical Research

Volumn 160, Issue 2, 2010, Pages 340-348

  Mueller, Cornelia K ^a   Thorwarth, Michael Wolf ^a   Schultze Mosgau, Stefan ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

angiogenesis; gene transfer; VEGF; wound healing

Indexed keywords

CYTOKINE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; VASCULAR ENDOTHELIUM;

ANIMALS; ANIMALS, OUTBRED STRAINS; CAPILLARIES; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; GENE THERAPY; GREEN FLUORESCENT PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; SURGERY, PLASTIC; TRANSFECTION; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950917670     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.12.007     Document Type: Article

References (33)

1. Pradier O., Christiansen H., Schmidberger H., et al. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 63 (2005) 1368
2. Ang K.K., Trotti A., Brown B.W., et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51 (2001) 571
3. Denham J.W., Hauer-Jensen M., and Peters L.J. Is it time for a new formalism to categorize normal tissue radiation injury?. Int J Radiat Oncol Biol Phys 50 (2001) 1105
4. Grabenbauer G.G., Rodel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only?. Radiother Oncol 66 (2003) 57
5. Kessler P., Grabenbauer G., Leher A., et al. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46 (2008) 1
6. Schultze-Mosgau S., Grabenbauer G.G., Radespiel-Troger M., et al. Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. Head Neck 24 (2002) 42
7. Schultze-Mosgau S., Rodel F., Radespiel-Troger M., et al. Vascularization of the area between free grafts and irradiated graft beds in the neck in rats. Br J Oral Maxillofac Surg 40 (2002) 37
8. Schultze-Mosgau S., Wehrhan F., Rodel F., et al. Improved free vascular graft survival in an irradiated surgical site following topical application of rVEGF. Int J Radiat Oncol Biol Phys 57 (2003) 803
9. Zhang F., Wallerand W., and Lineaweaver W.C. Growth factors and flap survival. Microsurgery 24 (2004) 162
10. Kim T.K., and Burgess D.J. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol 54 (2002) 897
11. Nabel E.G., Yang Z.Y., Plautz G., et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362 (1993) 844
12. Barger A.C., BeeuwkesR L.L.L., et al. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310 (1984) 175
13. Unger E.F., Goncalves L., Epstein S.E., et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol 85 (2000) 1414
14. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438 (2005) 932
15. Spilsbury K., Garrett K.L., Shen W.Y., et al. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157 (2000)
16. Gitay-Goren H., Soker S,Vlodavsky I., et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267 (1992)
17. Liu P.Y., Tong W., Liu K., et al. Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat. Wound Repair Regen 12 (2004)
18. Weibel E.R. Measuring through the microscope: Development and evolution of stereological methods. J Microsc 155 (1989)
19. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (New York, N.Y) 288 (2000) 669
20. Krisky D.M., Wolfe D., Goins W.F., et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 5 (1998) 1593
21. Lubiatowski P., Goldman C.K., Gurunluoglu R., et al. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 109 (2002) 1986
22. Cristiano R.J. Viral and non-viral vectors for cancer gene therapy. Anticancer Res 18 (1998) 3241
23. Nakagawa A., Makino H., Aoki M., et al. Improvement of survival of skin flaps by combined gene transfer of hepatocyte growth factor and prostacyclin synthase. J Gene Med 9 (2007) 1087
24. Benns J.M., Maheshwari A., Furgeson D.Y., et al. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 9 (2001) 123
25. Kang S.W., Lim H.W., Seo S.W., et al. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 29 (2008) 1109
26. Rinsch C., Quinodoz P., Pittet B., et al. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 8 (2001) 523
27. Spanholtz T., Maichle A., Niedworok C., et al. Timing and targeting of cell-based VEGF(165) gene expression in ischemic tissue. J Surg Res 151 (2009) 153
28. Popa E.R., van der Strate B.W., Brouwer L.A., et al. Dependence of neovascularization mechanisms on the molecular microenvironment. Tissue Eng 13 (2007) 2913
29. Sheridan M.H., Shea L.D., Peters M.C., et al. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 64 (2000) 91
30. King T.W., and Patrick Jr. C.W. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Materials Res 51 (2000) 383
31. Zhang H., Zhu S.J., Wang W., et al. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther 15 (2008) 40
32. Aluigi M., Fogli M., Curti A., et al. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem cells (Dayton, Ohio) 24 (2006) 454
33. Ozawa C.R., Banfi A., Glazer N.L., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113 (2004)